<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Obstet Gynecol</journal-id><journal-id journal-id-type="iso-abbrev">Obstet Gynecol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Obstetrics and gynecology</journal-title></journal-title-group><issn pub-type="ppub">0029-7844</issn><issn pub-type="epub">1873-233X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10201921</article-id><article-id pub-id-type="pmcid-ver">PMC10201921.1</article-id><article-id pub-id-type="pmcaid">10201921</article-id><article-id pub-id-type="pmcaiid">10201921</article-id><article-id pub-id-type="manuscript-id">NIHMS1865851</article-id><article-id pub-id-type="pmid">36897142</article-id><article-id pub-id-type="doi">10.1097/AOG.0000000000005117</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1865851</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1865851</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Medication Initiation and Treatment Discontinuation in Pregnant Compared With Nonpregnant People</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="KY">Kevin Y</given-names></name><degrees>MD MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jones</surname><given-names initials="HE">Hendr&#233;e E</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schiff</surname><given-names initials="DM">Davida M</given-names></name><degrees>MD MSc</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Martin</surname><given-names initials="CE">Caitlin E</given-names></name><degrees>MD MPH</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kelly</surname><given-names initials="JC">Jeannie C</given-names></name><degrees>MD MS</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carter</surname><given-names initials="EB">Ebony B</given-names></name><degrees>MD MPH</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bierut</surname><given-names initials="LJ">Laura J</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grucza</surname><given-names initials="RA">Richard A</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A7" ref-type="aff">7</xref></contrib></contrib-group><aff id="A1"><label>1</label>Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA</aff><aff id="A2"><label>2</label>Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC, USA</aff><aff id="A3"><label>3</label>Division of General Academic Pediatrics, Mass General Hospital for Children, Boston, MA, USA</aff><aff id="A4"><label>4</label>Department of Obstetrics and Gynecology and VCU Institute for Drug and Alcohol Studies, Virginia Commonwealth University School of Medicine, Richmond, VA, USA</aff><aff id="A5"><label>5</label>Division of Maternal-Fetal Medicine and the Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA</aff><aff id="A6"><label>6</label>Alvin J Siteman Cancer Center, Barnes Jewish Hospital, St. Louis, MO, USA</aff><aff id="A7"><label>7</label>Departments of Family and Community Medicine and Health and Outcomes Research, St. Louis University, St. Louis, MO, USA</aff><author-notes><corresp id="CR1">Corresponding Author: Kevin Y Xu, MD MPH, Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, <email>xukeviny@wustl.edu</email></corresp><fn fn-type="COI-statement" id="FN1"><p id="P28">Each author has confirmed compliance with the journal&#8217;s requirements for authorship.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>09</day><month>3</month><year>2023</year></pub-date><volume>141</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">436279</issue-id><fpage>845</fpage><lpage>853</lpage><pub-history><event event-type="nihms-submitted"><date><day>02</day><month>02</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 12:25:14.010"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1865851.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objective:</title><p id="P1">To examine the association between pregnancy and medication for opioid use disorder (MOUD) initiation and discontinuation among reproductive-age women receiving treatment for OUD in the United States.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We conducted a retrospective cohort study of people, gender recorded as female, ages 18&#8211;45 years, in the Merative<sup>&#8482;</sup> MarketScan<sup>&#174;</sup> Commercial and Multi-State Medicaid Databases (2006&#8211;2016). OUD and pregnancy status were identified based on inpatient or outpatient claims for established ICD-9/10 diagnosis and procedure codes. The main outcomes were buprenorphine and methadone initiation and discontinuation, determined using pharmacy and outpatient procedure claims. Analyses were conducted at the treatment episode level. Adjusting for insurance status, age, and co-occurring psychiatric and substance use disorders, we used logistic regression to estimate MOUD initiation, and Cox regression to estimate MOUD discontinuation.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Our sample included 101,772 reproductive-age people with OUD encompassing 155,771 treatment episodes (mean age 30.8 years, 64.4% Medicaid, 84.1% White), of whom 2,687 (3.2%, encompassing 3,325 episodes) were pregnant. In the pregnant group, 51.2% of treatment episodes (1,703/3,325) involved psychosocial treatment without MOUD, in comparison to 61.1% (93,156/152,446) in the non-pregnant comparator group. In adjusted analyses assessing likelihood of initiation for individual MOUDs, pregnancy status was associated with an increase in buprenorphine (adjusted odds ratio [aOR]=1.57 [95% CI=1.44, 1.70]) and methadone initiation (aOR=2.04 [1.82, 2.27]). MOUD discontinuation rates at 270 days were high for both buprenorphine (72.4% for non-pregnant vs 59.9% for pregnant episodes) and methadone (65.7% for non-pregnant vs 54.1% for pregnant episodes). Pregnancy was associated with a decreased likelihood of discontinuation at 270 days for both buprenorphine (adjusted hazard ratio [aHR]=0.71 [0.67, 0.76]) and methadone (aHR=0.68 [0.61, 0.75]), in comparison to non-pregnancy status.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">Although a minority of reproductive-age people with OUD in the United States are initiated on MOUD, pregnancy is associated with significant increase in treatment initiation and reduced risk of medication discontinuation.</p></sec></abstract><abstract id="ABS2" abstract-type="summary"><title>Pr&#233;cis:</title><p id="P5">This study uses administrative data to show that pregnancy is a time period of increased opioid use disorder treatment utilization, although treatment discontinuation remains very high.</p></abstract><kwd-group><kwd>pregnancy</kwd><kwd>opioid use disorder</kwd><kwd>perinatal</kwd><kwd>reproductive age</kwd><kwd>buprenorphine</kwd><kwd>methadone</kwd><kwd>retention</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>